Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-22

Clinical Trial Update: Chidamide in Combination With Abemaciclib and Endocrinotherapy(Doctor's Choice) in Breast Cancer Patients Previously Treated With Palbociclib [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating chidamide with abemaciclib and endocrine therapy in breast cancer patients previously treated with palbociclib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abemaciclib (abemaciclib)
  • Chidamide (chidamide)

Snippet

Sponsor: Biyun Wang, MD | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN